Impact of levosimendan on weaning from peripheral venoarterial extracorporeal membrane oxygenation in intensive care unit
Abstract Background Few data are available on the impact of levosimendan in refractory cardiogenic shock patients undergoing peripheral venoarterial extracorporeal membrane oxygenation (VA-ECMO). The aim of this study was to evaluate the impact of levosimendan on VA-ECMO weaning in patients hospital...
Main Authors: | Shamir Vally, Cyril Ferdynus, Romain Persichini, Bruno Bouchet, Eric Braunberger, Hugo Lo Pinto, Olivier Martinet, David Vandroux, Thomas Aujoulat, Jérôme Allyn, Nicolas Allou |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2019-02-01
|
Series: | Annals of Intensive Care |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13613-019-0503-1 |
Similar Items
-
Levosimendan in venoarterial ECMO weaning. Rational and design of a randomized double blind multicentre trial
by: Omar Ellouze, et al.
Published: (2021-08-01) -
How I approach weaning from venoarterial ECMO
by: Justin A. Fried, et al.
Published: (2020-06-01) -
Complication patterns in patients undergoing venoarterial extracorporeal membrane oxygenation in intensive care unit: Multiple correspondence analysis and hierarchical ascendant classification.
by: Jérôme Allyn, et al.
Published: (2018-01-01) -
Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis
by: Enrique Guilherme, et al.
Published: (2020-07-01) -
Update on Weaning from Veno-Arterial Extracorporeal Membrane Oxygenation
by: Enzo Lüsebrink, et al.
Published: (2020-04-01)